{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:13Z","timestamp":1767135253397,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd001820.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T00:00:00Z","timestamp":1184716800000}}],"reference-count":60,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001820.pub3","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T10:37:15Z","timestamp":1183459035000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dipyridamole for preventing stroke and other vascular events in patients with vascular disease"],"prefix":"10.1002","volume":"2010","author":[{"given":"Els LLM","family":"De Schryver","sequence":"first","affiliation":[{"name":"Rijnland Ziekenhuis Leiderdorp; Department of Neurology; Simon Smitweg 1 Leiderdorp Netherlands 2353 GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale","family":"Algra","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht; Julius Centre for Health Sciences and Primary Care; PO Box 85500 Utrecht Netherlands 3508 GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"van Gijn","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht; Department of Neurology; PO Box 85500 Utrecht Netherlands 3508 GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"10.1002\/14651858.CD001820.pub3-BIB0002|cit1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.STR.14.1.99","article-title":"Persantine aspirin trial in cerebral ischemia","volume":"14","author":"The American-Canadian Co-operative Study Group","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","article-title":"Persantine aspirin trial in cerebral ischemia. Part II: Endpoint results","volume":"16","author":"The American-Canadian Co-operative Study Group","year":"1985","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\"AICLA\" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\"AICLA\" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jama.1967.03130110091023","article-title":"Dipyridamole in the treatment of angina pectoris. A double-blind evaluation","volume":"201","author":"Sbar","year":"1967","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0006|cit6","first-page":"88","article-title":"Angina Pectoris: a double blind study with dipyridamole","volume":"18","author":"Becker","year":"1967","journal-title":"Journal of the Newark Beth Israel Hospital"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0007|cit7","first-page":"1933","article-title":"Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)","volume":"76","author":"Caneschi","year":"1985","journal-title":"Minverva Medica"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0008|cit8","first-page":"1933","article-title":"Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)","volume":"76","author":"Caneschi","year":"1985","journal-title":"Minverva Medica"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0009|cit9","first-page":"148","article-title":"Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study","volume":"88 Suppl 3","author":"Chairangasarit","year":"2005","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diab.38.4.491","article-title":"Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial","volume":"38","author":"The DAMAD Study Group","year":"1989","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diab.38.4.491","article-title":"Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial","volume":"38","author":"The DAMAD Study Group","year":"1989","journal-title":"Diabetes"},{"issue":"2","key":"10.1002\/14651858.CD001820.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000016044","article-title":"Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European\/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group","volume":"10","author":"Schryver","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT); randomised controlled trial","volume":"367","author":"The ESPRIT Study Group","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.STR.21.8.1122","article-title":"European Stroke Prevention Study","volume":"21","author":"ESPS Group","year":"1990","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0016|cit16","first-page":"S1","article-title":"European Stroke Prevention Study 2. Efficacy and safety data","volume":"151 Suppl","author":"The ESPS-2 Group","year":"1997","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/bmj.4.5627.366","article-title":"Dipyridamole: a controlled trial of its effect in acute myocardial infarction","volume":"4","author":"Gent","year":"1968","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0021|cit21","unstructured":"The profylaxis of thrombosis in new arteriovenous dialysis shunts in the arm by low-dose acetylsalicylic acid and dipyridamole Unpublished work 1992"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"Hess","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"Hess","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1532-5415.1970.tb02124.x","article-title":"Treatment of angina pectoris with dipyridamole: a double-blind study","volume":"18","author":"Igloe","year":"1970","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0025|cit25","first-page":"321","article-title":"Dipyridamole combined with acetylsalicylic acid versus acetylsalicylic acid alone in the treatment of peripheral vascular disease","volume":"3","author":"Catalano","year":"1984","journal-title":"International Angiology"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0026|cit26","first-page":"207","article-title":"Treatment of claudication with dipyridamole and aspirin","volume":"14","author":"Libretti","year":"1986","journal-title":"Monographs on Atherosclerosis"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0027|cit27","first-page":"266","article-title":"Antiplatelet therapy in coronary disease progression reduced infarction and new lesion formation","volume":"80 Suppl II","author":"Chesebro","year":"1989","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0028|cit28","first-page":"558","article-title":"Comparative trials of sulphinpyrazone and aspirin + dipyridamole in acute myocardial infarction","volume":"34","author":"Misra","year":"1983","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","article-title":"The Persantine-Aspirin reinfarction study","volume":"62","author":"The Persantine-Aspirin Reinfarction Study (PARIS) research group","year":"1980","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","article-title":"The Persantine-Aspirin reinfarction study","volume":"62","author":"The Persantine-Aspirin Reinfarction Study (PARIS) research group","year":"1980","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0735-1097(86)80489-2","article-title":"Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin","volume":"7","author":"Klimt","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/euhj.2001.2623","article-title":"Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study","volume":"22","author":"Picano","year":"2001","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0033|cit33","first-page":"267","article-title":"Treatment of unstable angina with dipyridamole combined with low doses of aspirin. A multicenter pilot double-blind controlled study","volume":"39","author":"Prandoni","year":"1991","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0034|cit34","unstructured":"Gentile R Lagana B Calcagni S Sorgia MC Baratta L Efficacy of platelet-inhibiting agents in the prevention of reinfarction in smoker patients Proceedings of X World Congress of Cardiology, Washington, USA 1986 302 (Abstract 1724)"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0037|cit35","first-page":"429","article-title":"Long-term results with conservative treatment of occlusive arteriopathies","volume":"25","author":"Schoop","year":"1984","journal-title":"Internist"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0035|cit36","first-page":"49","article-title":"Experimentelle und klinische Studien zu der sekund\u00e4ren Pr\u00e4vention der peripheren Arteriosklerose","volume-title":"Thrombozytenfunktionshemmer, Wirkungsmechanismen, Dosierung und praktische Anwendung","author":"Schoop","year":"1983"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0036|cit37","first-page":"137","article-title":"Prevention of peripheral arterial occlusive disease with antiaggregants","volume":"50","author":"Schoop","year":"1983","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0038|cit38","first-page":"49","article-title":"Experimentelle und klinische Studien zu der sekund\u00e4ren Pr\u00e4vention der peripheren Arteriosklerose","volume-title":"Thrombozytenfunktionshemmer, Wirkungsmechanismen, Dosierung und praktische Anwendung","author":"Schoop","year":"1983"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.1.5644.614","article-title":"Controlled trial of dipyridamole in cerebral vascular disease","volume":"i","author":"Acheson","year":"1969","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0044|cit44","first-page":"367","article-title":"Pr\u00e9vention des r\u00e9cidives des accidents vasculaires c\u00e9r\u00e9braux isch\u00e9miques par les anti-agr\u00e9gants plaquettaires. R\u00e9sultats d'un essai th\u00e9rapeutique control\u00e9 de 3 ans","volume":"138","author":"Guiraud-Chaumeil","year":"1982","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0045|cit45","first-page":"367","article-title":"Pr\u00e9vention des r\u00e9cidives des accidents vasculaires c\u00e9r\u00e9braux isch\u00e9miques par les anti-agr\u00e9gants plaquettaires. R\u00e9sultats d'un essai th\u00e9rapeutique control\u00e9 de 3 ans","volume":"138","author":"Guiraud-Chaumeil","year":"1982","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/diacare.9.2.140","article-title":"Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates","volume":"9","author":"Colwell","year":"1986","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0735-1097(94)00331-J","article-title":"Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy","volume":"25","author":"White","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0021-9681(67)90048-3","article-title":"Treatment of angina pectoris with dipyridamole: a long-term double blind study","volume":"20","author":"Wirecki","year":"1967","journal-title":"Journal of Chronic Diseases"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","article-title":"Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia","volume":"60","author":"Algra","year":"1996","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jnnp.66.5.557","article-title":"Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone?","volume":"66","author":"Algra","year":"1999","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.66.2.255","article-title":"Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin","volume":"66","author":"Algra","year":"1999","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0054|cit54","article-title":"Analysing and presenting results. Cochrane Handbook of Systematic Review of Interventions 4.2.5 [Updated May 2005]; Section 8.8","volume-title":"The Cochrane Library, Issue 3, 2005","author":"Deeks","year":"2005"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","author":"The Dutch TIA Trial Study Group","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198705143162005","article-title":"Modern drug therapy: dipyridamole","volume":"316","author":"FitzGerald","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0057|cit57","unstructured":"Kaye J A trial to evaluate the relative roles of dipyridamole and aspirin in the prevention of deep vein thrombosis in stroke patients Boehringer Ingelheim Internal Report 1990"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"UK-TIA Study Group","year":"1991","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0140-6736(92)90608-6","article-title":"Secondary prevention of stroke","volume":"339","author":"Warlow","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD001820.pub3-BIB0060|cit60","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001820.pub2","article-title":"Dipyridamole for preventing stroke and other vascular events in patients with vascular disease","author":"Schryver","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001820.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:10:32Z","timestamp":1765757432000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001820.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001820.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,18]]}}}